On July 8, 2026, the clinical trial registry updated the status of NCT05509569 to completed. The study, titled A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema, examined the use of icatibant in a pediatric population. Icatibant is an approved compound. No phase was listed for this study in the available data.
The trial's status change to completed indicates that the study has concluded its planned activities as recorded in the registry. No results have been reported alongside this status update in the data provided. This brief does not describe outcomes, efficacy, or safety findings, since none were included in the event information.
The trial record can be found under identifier NCT05509569 in the clinical trials database. Readers seeking details on the study design, participant criteria, or future results should consult the official registry listing directly.
For more background on icatibant, including its approved uses and general profile, readers can refer to the compound overview.